Comparing the current results to its competitors, Butterfly Network Inc reported Revenue increase in the 1 quarter 2026 by 28.97 % year on year. The sales growth was above Butterfly Network Inc 's competitors' average revenue growth of 6.58 %, achieved in the same quarter.
Butterfly Network Inc , slower than the average decrease reported by the company's competitors of -14.23 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -14.23 %
Butterfly Network Inc 's Comment on Competition and Industry Peers
Butterfly competes with established providers of conventional and handheld ultrasound systems. The company uses its Ultrasound-on-Chip™ semiconductor technology, which does not depend on lead-based piezoelectric crystals. This contrasts with many competitors who use lead-based crystals and rely on exemptions under the EU's RoHS directive. Butterfly's technology allows for versatile whole-body scans and maintains RoHS compliance without depending on potentially temporary exemptions.
May 5, 2025
In a landscape where many companies face revenue declines, Butterfly Network, Inc. (NYSE: BFLY) has emerged as a notable outlier in its first quarter financial results for 2025. This Burlington, Massachusetts-based digital health innovator, known for its portable and semiconductor-based ultrasound technology, reported a commendable revenue increase of 17.97% year-on-year. This performance starkly contrasts the broader industry trend, where competitors recorded average revenue contractions of 3.9%.Butterfly Network s CEO Joseph DeVivo expressed optimism about the company’s trajectory, indicating that 2025 is off to a promising start. Such a robust revenue growth is particularly impressive given the competit...
November 11, 2024
In a striking recognition of innovation in healthcare, Butterfly Network, Inc. (NYSE: BFLY), a pioneering digital health company, recently celebrated its third-generation handheld ultrasound device, the Butterfly iQ3, winning the prestigious Best Medical Technology Award at the 2024 Prix Galien USA Awards. This accolade, bestowed by the Galien Foundation, underscores the device’s transformative potential in the realm of portable imaging and its capability to deliver sophisticated diagnostic capabilities at the point of care.The award comes at a pivotal time for Butterfly, as the company reported a remarkable 31.54% year-over-year increase in revenue for the third quarter of 2024. This robust growth sharply...
November 8, 2024
Butterfly Network, Inc. (NYSE: BFLY), a pioneering digital health company, has etched its mark in the medical technology landscape by winning the coveted Best Medical Technology Award at the 2024 Prix Galien USA Awards. This prestigious accolade highlights Butterfly s groundbreaking work in transforming healthcare through state-of-the-art portable ultrasound technology and empowering software innovations. Celebrating Innovation in HealthcareThe Prix Galien USA Awards, established by the Galien Foundation, is dedicated to recognizing innovation in the field of life sciences, particularly in medical technology. The award is an acknowledgment of the significance that effective medical solutions bring to patient...
September 5, 2024
Revolutionizing Diagnostics: Butterfly Network’s Groundbreaking Innovations in Ultrasound Technology In a move poised to redefine diagnostic approaches in healthcare, Butterfly Network Inc. a pioneering digital health company headquartered in Burlington, Massachusetts, has made significant strides in the ultrasound industry. Recent announcements highlight the company s commitment to innovation through the introduction of its next-generation Butterfly iQ3 portable ultrasound system in Europe and its foray into the bladder scanning market with the release of the iQ+ Bladder in the United States. These developments signal a broader trend towards integrating advanced technology into health care delivery, aimed...
February 13, 2024
Butterfly Network, a digital health company specializing in portable ultrasound technology, has announced the launch of its latest product, the Butterfly iQ3. Following FDA clearance last month, the handheld point-of-care ultrasound system has been made available in the United States. With its advanced semiconductor chip technology and intuitive software, the Butterfly iQ3 is set to revolutionize care delivery and diagnostics in healthcare settings.The Butterfly iQ3 is the third-generation POCUS system developed by Butterfly Network, known for their innovative approach to transforming healthcare. POCUS is a technology that allows medical professionals to conduct ultrasounds at the bedside, bringing the power...
January 8, 2024
In a major breakthrough in the field of healthcare technology, Butterfly Network, Inc. (Butterfly) has announced that its next-generation handheld ultrasound system, the Butterfly iQ3, has received clearance from the U.S. Food and Drug Administration (FDA). This remarkable achievement marks a significant step forward in portable and accessible healthcare, revolutionizing the way medical professionals diagnose and monitor patients. With its semiconductor-based ultrasound technology and intuitive software, the Butterfly iQ3 promises to transform the landscape of point-of-care ultrasound (POCUS) systems.The Evolution of Butterfly Network s Ultrasound Systems:Butterfly Network has cemented its position as a lead...
Aclarion Inc is a technology company that operates on a software-as-a-service (SaaS) business model. They provide their customers with cloud-based solutions, enabling them to streamline and automate their business processes efficiently. Aclarion offers a range of customizable software solutions, including data management, project management, and collaboration tools, tailored to meet the specific needs of their clients.
Koninklijke Philips Nv operates as a diversified technology company, focusing on areas such as healthcare, consumer lifestyle, and lighting. The company provides a wide range of products and solutions, including medical imaging equipment, home appliances, personal care products, and lighting solutions. Philips Nv's business model involves innovation-driven research and development, strategic partnerships, and a global distribution network to deliver its products and services to customers worldwide.
Hologic Incs business model focuses on developing and commercializing medical technologies and diagnostic products, primarily dedicated to womens healthcare. Their offerings include innovative solutions for breast and skeletal health, gynecological health, and surgical products, aiming to improve patient outcomes and enhance healthcare practices.
GE Healthcare Technologies Inc's business model is focused on providing innovative medical devices, healthcare information technology, and healthcare services to improve patient care and outcomes. The company offers a wide range of products and solutions in areas such as medical imaging, patient monitoring, diagnostics, and healthcare IT. They also collaborate with healthcare providers and partners to offer integrated solutions and support throughout the entire healthcare ecosystem.
Check Cap Ltd is a medical technology company that develops and commercializes an ingestible imaging capsule that allows for the detection and monitoring of colorectal polyps. Their business model revolves around manufacturing and selling this capsule device while also providing associated services and support to healthcare professionals and patients.
Sources:
Butterfly Network Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Butterfly Network Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
